TLDR Bitwise filed the first ETF proposal to track Hyperliquid’s HYPE token with the SEC HYPE token fell 11% to $40.51 with an $11 billion market cap, ranking as 21st-largest cryptocurrency SEC delayed action on several altcoin ETF proposals including SUI, PENGU, INJ, SEI, and Avalanche funds Competition heats up as Aster DEX surpassed Hyperliquid [...] The post Bitwise Files First Hyperliquid ETF Proposal as Crypto Futures Market Heats Up appeared first on CoinCentral.TLDR Bitwise filed the first ETF proposal to track Hyperliquid’s HYPE token with the SEC HYPE token fell 11% to $40.51 with an $11 billion market cap, ranking as 21st-largest cryptocurrency SEC delayed action on several altcoin ETF proposals including SUI, PENGU, INJ, SEI, and Avalanche funds Competition heats up as Aster DEX surpassed Hyperliquid [...] The post Bitwise Files First Hyperliquid ETF Proposal as Crypto Futures Market Heats Up appeared first on CoinCentral.

Bitwise Files First Hyperliquid ETF Proposal as Crypto Futures Market Heats Up

TLDR

  • Bitwise filed the first ETF proposal to track Hyperliquid’s HYPE token with the SEC
  • HYPE token fell 11% to $40.51 with an $11 billion market cap, ranking as 21st-largest cryptocurrency
  • SEC delayed action on several altcoin ETF proposals including SUI, PENGU, INJ, SEI, and Avalanche funds
  • Competition heats up as Aster DEX surpassed Hyperliquid in trading volume, reaching $35.8 billion vs $10 billion
  • The ETF would offer in-kind redemptions and directly hold HYPE tokens, requiring both S-1 and 19b-4 filings for approval

Crypto asset manager Bitwise Investment Advisers has submitted the first exchange-traded fund proposal to track Hyperliquid’s native HYPE token. The S-1 filing with the Securities and Exchange Commission represents a new step in expanding crypto ETF offerings beyond Bitcoin and Ethereum.

Hyperliquid operates as a Layer 1 blockchain designed for decentralized finance applications. The platform focuses primarily on perpetual futures trading through its decentralized exchange.

The HYPE token serves multiple functions within the ecosystem. It provides trading fee discounts on the decentralized exchange and pays transaction fees on the blockchain network.

HYPE experienced price pressure during the filing period. The token dropped 11% to $40.51 over 24 hours according to market data.

The cryptocurrency maintains a circulating supply of 270.8 million tokens. With its current price, HYPE holds an $11 billion market capitalization, making it the 21st-largest cryptocurrency by market value.

Regulatory Landscape Remains Complex

The SEC delayed action on multiple altcoin ETF proposals during the same period. Canary’s spot SUI and PENGU fund applications face extended review timelines.

The regulator also postponed decisions on Canary’s staked INJ and SEI fund proposals. Spot Avalanche ETF applications from Grayscale and VanEck received similar treatment.

Dozens of crypto-related ETF filings currently await regulatory approval. The backlog reflects ongoing regulatory uncertainty in the digital asset space.

Hashdex expanded its existing crypto ETF to include XRP and Solana. This move followed the SEC’s recent approval of broader listing standards for cryptocurrency products.

Competition Intensifies Among DEX Platforms

Trading competition among perpetual futures platforms has increased substantially. Aster launched its token earlier this month and quickly gained market share from established players.

Aster’s trading volume surged past Hyperliquid’s performance metrics. The BNB Chain-native platform processed $35.8 billion in 24-hour volume compared to Hyperliquid’s $10 billion.

Open interest data shows Aster’s rapid growth trajectory. The platform’s open interest reached $1.15 billion on Thursday, up from under $143 million on September 20.

Hyperliquid’s open interest declined 1.85% to $2.2 billion over the same period. The established platform has long held the leading position in onchain futures trading.

Total perpetual trading volumes across decentralized exchanges hit $70 billion on Thursday. This represents an all-time high for the DEX futures market.

The Bitwise filing includes standard ETF features for institutional investors. The fund would offer in-kind creation and redemption mechanisms, allowing shares to be exchanged for actual HYPE tokens rather than cash.

The SEC approved in-kind creation and redemption for crypto products in July. Regulators described this structure as more cost-effective and efficient for market participants.

Bitwise must file additional paperwork before launch can proceed. The company needs Form 19b-4 approval to begin the formal SEC review process, which can take up to 240 days.

The filing notes that no Hyperliquid futures contracts currently exist on CFTC-regulated exchanges. This may complicate the approval timeline under recent SEC guidance for crypto ETFs.

The post Bitwise Files First Hyperliquid ETF Proposal as Crypto Futures Market Heats Up appeared first on CoinCentral.

Market Opportunity
Hyperliquid Logo
Hyperliquid Price(HYPE)
$25.86
$25.86$25.86
-0.30%
USD
Hyperliquid (HYPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29